90K (Mac-2 BP) and galectins in tumor progression and metastasis
about
Galectin-3 and Beclin1/Atg6 genes in human cancers: using cDNA tissue panel, qRT-PCR, and logistic regression model to identify cancer cell biomarkersMac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cellsSialoglycoproteins and N-glycans from secreted exosomes of ovarian carcinoma cellsIdentification of novel tumor-associated cell surface sialoglycoproteins in human glioblastoma tumors using quantitative proteomicsQuantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.Integrated analysis of global mRNA and protein expression data in HEK293 cells overexpressing PRL-1.Tumor biomarker glycoproteins in the seminal plasma of healthy human males are endogenous ligands for DC-SIGN.Carbohydrate recognition by boronolectins, small molecules, and lectins.Galectin-1 and its involvement in hepatocellular carcinoma aggressivenessIdentification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes.Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.The promigratory activity of the matricellular protein galectin-3 depends on the activation of PI-3 kinase.Investigation of galectin-3 function in the reproductive tract by identification of binding ligands in human seminal plasmaExpression and significance of 90K/Mac-2BP in prostate cancer.Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomasPlasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma.The role of galectin-3 and galectin-3-binding protein in venous thrombosis.Co-purification of Mac-2 binding protein with galectin-3 and association with prostasomes in human semenPrognostic relevance of LGALS3BP in human colorectal carcinoma.Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.Extracellular Vesicles from Ovarian Carcinoma Cells Display Specific Glycosignatures.Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patientsSpectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer.Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas.Shoc2-tranduced ERK1/2 motility signals--Novel insights from functional genomics.Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancerAlteration of matrix metalloproteinase-3 O-glycan structure as a biomarker for disease activity of rheumatoid arthritis.Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.90K Glycoprotein Promotes Degradation of Mutant β-Catenin Lacking the ISGylation or Phosphorylation Sites in the N-terminus.Biomarkers for malignant pleural mesothelioma: current status.Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer.Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model.A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus.Up-regulation of Mac-2 binding protein by hTERT in gastric cancer.LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention.Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis.
P2860
Q21134996-6C566AA0-9433-45F0-ACE4-CB8FBAC9AF60Q28274894-4F73B1D1-1CFA-418A-8ACF-2CC48BEAF7CCQ28535417-62530942-A3A9-4026-AD4D-26AF52CD9D47Q28544645-E450A604-3DDC-4EA2-9952-1F6220B9C492Q30576595-2891FDFE-5826-4715-8A0B-4336FB43AAAAQ30665898-88AD841C-A3AF-47E0-97D0-532465E72FB1Q31031940-7798971C-7E32-4426-AD31-19BB6A72F768Q33691290-E1260A21-1295-4BCE-B9C7-306D399EA83FQ33692511-F5A04E28-2C05-4DF2-8343-1EEB41F6895EQ33812900-A4EB71C1-7D9D-453E-9A74-5517DFB9D964Q34058682-347754CC-1360-42DE-8DD8-DDA82BB49885Q34117467-6235F51A-9F99-4D93-AB42-2C5C4734965FQ34268107-6AB84892-B442-4955-AB54-53D24A1E4B83Q34515531-D53926BC-89FD-4201-948F-4AFF70A1E077Q34580364-1BCF8BB3-91B2-48B8-BC33-EFD0112D2235Q34785324-789C9DF3-4744-4C21-92E0-16636E6F7CD9Q35063118-1902B0AD-B3FC-46A7-B12B-CD3E488C39A4Q35101910-2F13E79A-B1A3-4033-BD33-1E2FF763F148Q35111396-C11D976E-6029-487C-A55B-B8D3EBA6024DQ35171280-34D1A8E4-EC1A-41FA-B7D8-CA2F82B4D02DQ35534585-98D9F696-7D62-4079-ABBA-8CCEA348CD15Q35899039-814AFEAA-6E89-4763-ABF3-0A6967746293Q35931701-35AE29E4-ECA9-4895-8E8A-0E02A4C30023Q35965881-4E85D539-F395-470B-8A78-6FE267716DACQ36139088-C0E80541-70BE-4AE9-A5BD-F6D61F293EFAQ36184329-9EAE2FC2-4DB5-448B-A46A-0DA8818821E0Q36408948-6185F423-D6D9-4018-B8C4-C97D60011ADCQ36497940-86ABFAE6-0C85-40D5-8EAD-4470256EB0CEQ36677993-C1A2AFA1-6E50-444D-80F7-0919B7E16B57Q36759226-6A0840BB-06D4-4B55-A023-7031681E3F05Q36923243-BCE7B043-8629-4DD3-911C-5D0576781F87Q37061114-88CA51B3-F2DF-4E4D-A284-6BA56235D03FQ37284950-4467917C-737C-489D-8EC9-7CC94017F41EQ37335377-12A633C5-ECD8-4E74-A8AE-51DC191E30C2Q37363290-0B094045-8FD8-4D70-822B-F3A5099CE6AFQ37423079-D63FBC3E-DDC8-48DE-98B6-8AC0A0CC4009Q37742466-1BF77744-B657-4E1E-8A51-394AD9654C3CQ38307280-6CFB27B1-EA30-49A9-A3DF-73E8459005C7Q39041034-520A140D-C715-40E4-AF27-CD82489AF393Q39138238-C3D309C4-CC7D-4C5D-AB89-2ED197E32951
P2860
90K (Mac-2 BP) and galectins in tumor progression and metastasis
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
90K (Mac-2 BP) and galectins in tumor progression and metastasis
@ast
90K (Mac-2 BP) and galectins in tumor progression and metastasis
@en
90K (Mac-2 BP) and galectins in tumor progression and metastasis
@nl
type
label
90K (Mac-2 BP) and galectins in tumor progression and metastasis
@ast
90K (Mac-2 BP) and galectins in tumor progression and metastasis
@en
90K (Mac-2 BP) and galectins in tumor progression and metastasis
@nl
prefLabel
90K (Mac-2 BP) and galectins in tumor progression and metastasis
@ast
90K (Mac-2 BP) and galectins in tumor progression and metastasis
@en
90K (Mac-2 BP) and galectins in tumor progression and metastasis
@nl
P2093
P3181
P1476
90K (Mac-2 BP) and galectins in tumor progression and metastasis
@en
P2093
Alba Cumashi
Antonino Grassadonia
Enza Piccolo
Ida Iurisci
Maurizia D'Egidio
Mauro Piantelli
Nicola Tinari
Pasquale Innominato
Stefano Iacobelli
P3181
P356
10.1023/B:GLYC.0000014085.00706.D4
P407
P50
P577
2004-01-01T00:00:00Z
P6179
1005565594